Net income
150 million USD
2025-10-01 – 2026-09-30
Fundies. English
MEDNAX, INC.
EDGAR170 filing records in this dataset, filed from 1996-05-10 to 2026-10-29. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 312 million USD Source
Exact value
311916000 USD
- Long-term debt including current maturities
- 611 million USD Source
Exact value
611200000 USD
- Shares outstanding
- 78.1 million shares Source
Exact value
78092928 shares
Reported share-count change
-9.02% · -7.74 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
227 million USD
2025-10-01 – 2026-09-30
Exact inputs and evidence
- Operating cash flow: 271091000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: 156989000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -129847000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -4524000 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -129847000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: 112783000 USD · 2026-01-01 – 2026-09-30 Source
- Operating cash flow: -4524000 USD · 2026-01-01 – 2026-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-29.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 11 of 11 periods available· newest 2025-12-31
- Total liabilities: 11 of 11 periods available· newest 2025-12-31
- Current assets: 11 of 11 periods available· newest 2025-12-31
- Current liabilities: 11 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
- Long-term debt including current maturities: 10 of 11 periods available· newest 2024-12-31
- Shares outstanding: 11 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 264.46 millionPrior period
−USD 99.07 million
–
Current period
USD 165.39 million
–
Exact inputs and evidence
165388000 − -99069000 = 264457000 USD
-99069000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source165388000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+31.2%Prior period
USD 206.57 million
–
Current period
USD 271.09 million
–
Exact inputs and evidence
271091000 − 206573000 = 64518000 USD
206573000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source271091000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | USD 324.91 million Exact valueExact value: 324914000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 443.78 million Exact valueExact value: 443778000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | USD 320.37 million Exact valueExact value: 320372000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 511.38 million Exact valueExact value: 511378000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | USD 268.63 million Exact valueExact value: 268629000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 313.71 million Exact valueExact value: 313708000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 1.5 billion Exact valueExact value: -1497702000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 357.71 million Exact valueExact value: 357711000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 796.49 million Exact valueExact value: -796488000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 204.62 million Exact valueExact value: 204620000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | USD 130.96 million Exact valueExact value: 130964000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 76.74 million Exact valueExact value: 76737000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | USD 66.34 million Exact valueExact value: 66335000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 166.94 million Exact valueExact value: 166941000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 60.41 million Exact valueExact value: -60408000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 137.33 million Exact valueExact value: 137325000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 99.07 million Exact valueExact value: -99069000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 206.57 million Exact valueExact value: 206573000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 165.39 million Exact valueExact value: 165388000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 271.09 million Exact valueExact value: 271091000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
170 filings · 4,738 latest values · 4,738 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000893949, 893949, MD, edgar:893949
Also known as MEDNAX, INC., Mednax, Inc., PEDIATRIX MEDICAL GROUP INC, Pediatrix Medical Group, Inc.